{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:01:02Z","timestamp":1648969262313},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,9,1]],"date-time":"1988-09-01T00:00:00Z","timestamp":589075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatr Neurol Sci"],"published-print":{"date-parts":[[1988,9]]},"DOI":"10.1007\/bf00380974","type":"journal-article","created":{"date-parts":[[2004,11,7]],"date-time":"2004-11-07T05:00:41Z","timestamp":1099803641000},"page":"320-326","source":"Crossref","is-referenced-by-count":1,"title":["Plasma levels of fluphenazine and prolactin in psychiatric patients"],"prefix":"10.1007","volume":"237","author":[{"given":"Toshinori","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dermot A.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman W.","family":"Imlah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1192\/bjp.128.5.451","volume":"128","author":"P Andrews","year":"1976","unstructured":"Andrews P, Hall JN, Snaith RP (1976) A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients. Br J Psychiatry 128:421?425","journal-title":"Br J Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1192\/bjp.149.6.726","volume":"149","author":"JS Bamrah","year":"1986","unstructured":"Bamrah JS, Kumar V, Kraska J, Soni SD (1986) Interactions between procyclidine and neuroleptic drugs: Some pharmacological and clinical aspects. Br J Psychiatry 149:726?733","journal-title":"Br J Psychiatry"},{"key":"CR3","first-page":"399","volume":"24","author":"GM Besser","year":"1980","unstructured":"Besser GM, Yeo T, Delitala G, Grossman AB (1980) Alteration of prolactin secretion by centrally acting drugs: In long term effects of neuroleptics. Adv Biochem Psychopharmacol 24:399?406","journal-title":"Adv Biochem Psychopharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/endo-99-5-1407","volume":"99","author":"GM Brown","year":"1976","unstructured":"Brown GM, Seeman P, Lee T (1976) Dopamine\/neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99:1407?1410","journal-title":"Endocrinology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/ajp.138.4.570","volume":"138","author":"WA Brown","year":"1981","unstructured":"Brown WA, Laughren T (1981) Low serum prolactin and early relapse following neuroleptic withdrawal. Am J Psychiatry 138:237?239","journal-title":"Am J Psychiatry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1192\/bjp.138.6.490","volume":"138","author":"KH Cheung","year":"1981","unstructured":"Cheung KH (1981) Schizophrenics fully remitted on neuroleptics for 3?5 years ? To stop or continue drugs? Br J Psychiatry 138:490?494","journal-title":"Br J Psychiatry"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0447.1981.tb00794.x","volume":"64","author":"G Chouinard","year":"1981","unstructured":"Chouinard G, Annable L, Jones BD, Collu R (1981) Lack of tolerance of long-term neuroleptic treatment in dopamine tuberoinfundibular system. Acta Psychiatr Scand 64:353?362","journal-title":"Acta Psychiatr Scand"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0447.1978.tb06909.x","volume":"57","author":"SJ Dencker","year":"1978","unstructured":"Dencker SJ, Johansson R, Lundin L, Malm U (1978) High doses of fluphenazine enanthate in schizophrenia. Acta Psychiatr Scand 57:405?414","journal-title":"Acta Psychiatr Scand"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1981.tb00644.x","volume":"63","author":"SJ Dencker","year":"1981","unstructured":"Dencker SJ, Enoksson P, Johansson R, Ludin L, Malm U (1981) Late (4?8 years) outcome of treatment with megadoses of fluphenazine enanthate in drug-refractory schizophrenics. Acta Psychiatr Scand 63:1?12","journal-title":"Acta Psychiatr Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.1971.tb03699.x","volume":"47","author":"J Denham","year":"1973","unstructured":"Denham J, Adamson L (1973) The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta Psychiatr Scand 47:420?430","journal-title":"Acta Psychiatr Scand"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archpsyc.1980.01780190089011","volume":"37","author":"PT Donlon","year":"1980","unstructured":"Donlon PT, Hopkin JT, Tupin JP, Wicks JJ, Wahba M, Meadow A (1980) Haloperidol for acute schizophrenic patients. An evaluation of three oral regimens. Arch Gen Psychiatry 37:691?695","journal-title":"Arch Gen Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"JP Feighner","year":"1973","unstructured":"Feighner JP, Robins E, Guze SB, Woodruf RA, Winokur G, Munoz R (1973) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57?63","journal-title":"Arch Gen Psychiatry"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.1977.01770140061008","volume":"34","author":"SC Goldberg","year":"1977","unstructured":"Goldberg SC, Schooler NR, Hogarty GE, Roper M (1977) Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy. Arch Gen Psychiatry 34:171?184","journal-title":"Arch Gen Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1177\/27.8.383827","volume":"27","author":"PC Goldsmith","year":"1979","unstructured":"Goldsmith PC, Cronin MJ, Weiner RI (1979) Dopamine receptor sites in the anterior pituitary. J Histochem Cytochem 27:1205?1207","journal-title":"J Histochem Cytochem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archpsyc.1978.01770250110011","volume":"35","author":"PH Gruen","year":"1978","unstructured":"Gruen PH, Sachar EJ, Langer G, Altman N, Leifer M, Frantz A, Halpern FS (1978a) Prolactin responses to neuroleptics in normal and schizophrenic subjects. Arch Gen Psychiatry 35:108?116","journal-title":"Arch Gen Psychiatry"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archpsyc.1978.01770340072008","volume":"35","author":"PH Gruen","year":"1978","unstructured":"Gruen PH, Sachar EJ, Altman N, Langer G, Tabrizi MA, Halpern FS (1978b) Relation of plasma prolactin to clinical response in schizophrenic patients. Arch Gen Psychiatry 35:1222?1227","journal-title":"Arch Gen Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","volume":"1","author":"SF Hirsch","year":"1973","unstructured":"Hirsch SF, Gaind R, Stevens BC, Wing JK (1973) Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine. Double-blind placebo trial. Br Med J 1:633?637","journal-title":"Br Med J"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archpsyc.1977.01770150055005","volume":"34","author":"GE Hogarty","year":"1977","unstructured":"Hogarty GE, Ulrich R (1977) Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. Arch Gen Psychiatry 34:297?301","journal-title":"Arch Gen Psychiatry"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archpsyc.1979.01780120013001","volume":"36","author":"GE Hogarty","year":"1979","unstructured":"Hogarty GE, Schooler NR, Ulrich R, Mussare F, Ferro P, Herron E (1979) Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Arch Gen Psychiatry 36:1283?1294","journal-title":"Arch Gen Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ajp.139.11.1466","volume":"139","author":"LE Hollister","year":"1982","unstructured":"Hollister LE, Kim DY (1982) Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients. Am J Psychiatry 139:1466?1468","journal-title":"Am J Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0447.1983.tb00351.x","volume":"67","author":"EAW Johnson","year":"1983","unstructured":"Johnson EAW, Pasterski G, Ludlow JM, Streek K, Taylor RDW (1983) The discountinuance of maintenance neuroleptic therapy in chronic schizophrenic patients. Drug and social consequences. Acta Psychiatr Scand 67:339?352","journal-title":"Acta Psychiatr Scand"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpsyc.1983.01790070083010","volume":"40","author":"JM Kane","year":"1983","unstructured":"Kane JM, Rifkin A, Woerner M, Reardon G, Sarantakos S, Schiebel D, Ramos-Lorenzi J (1983) Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates. Arch Gen Psychiatry 40:893?896","journal-title":"Arch Gen Psychiatry"},{"key":"CR23","volume-title":"Brief Psychiatric Rating Scale. Glossaries and rating instructions","author":"T Kolakowska","year":"1976","unstructured":"Kolakowska T (1976) Brief Psychiatric Rating Scale. Glossaries and rating instructions. Oxford University, Oxford"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S0033291700056488","volume":"5","author":"T Kolakowska","year":"1975","unstructured":"Kolakowska T, Wiles DH, McMeilly AS, Gelder MG (1975) Correlation between plasma levels of prolactin and chlorpromazine in psychatric patients. Psychol Med 5:214?216","journal-title":"Psychol Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1192\/bjp.139.5.400","volume":"139","author":"T Kolakowska","year":"1981","unstructured":"Kolakowska T, Braddock L, Wiles D, Franklin M, Gelder M (1981) Neueroendocrine tests during treatment with neuroleptic drugs. 1. Plasma prolactin response to haloperidol challenge. Br J Psychiatry 139:400?412","journal-title":"Br J Psychiatry"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.146.3.229","volume":"146","author":"T Kolakowska","year":"1985","unstructured":"Kolakowska T, Williams AO, Ardern M, Reveley MA, Jambor K, Gelder MG, Mandelbrote M (1985) Schizophrenia with good and poor outcome. I. Early clinical features, response to neuroleptics and signs of organic dysfunction. Br J Psychiatry, 146:229?246","journal-title":"Br J Psychiatry"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1974.tb02813.x","volume":"3","author":"AS McNeilly","year":"1974","unstructured":"McNeilly AS, Hagen C (1974) Prolactin, TSH, LH and FSH responses to a combined LHRH\/TRH test at different stages of the menstrual cycle. Clin Endocrinol 3:427?435","journal-title":"Clin Endocrinol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archpsyc.1981.01780270081011","volume":"38","author":"R Neborsky","year":"1981","unstructured":"Neborsky R, Janowsky E, Munson E and Depry D (1981) Rapid treatment of acute psychotic symptoms with highand low-dose haloperidol. Behavioral considerations. Arch Gen Psychiatry 38:195?199","journal-title":"Arch Gen Psychiatry"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus WS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11?19","journal-title":"Acta Psychiatr Scand"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0364-7722(81)90008-4","volume":"5","author":"J Tegeler","year":"1981","unstructured":"Tegeler J, Lehmann E (1981) A follow-up study of schizophrenic outpatients treated with depot-neuroleptics. Prog Neuro-Psychopharmacol 5:79?90","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.1978.tb01636.x","volume":"6","author":"DH Wiles","year":"1978","unstructured":"Wiles DH, Franklin M (1978) Radioimmunoassay for fluphenazine in human plasma. Br J Clin Pharmacol 6:265?268","journal-title":"Br J Clin Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2125.1979.tb01045.x","volume":"8","author":"DH Wiles","year":"1979","unstructured":"Wiles DH, Gelder MG (1979) Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injection of fluphenazine decanoate. Br J Clin Pharmacol 8:565?570","journal-title":"Br J Clin Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0033291700015841","volume":"6","author":"DH Wiles","year":"1976","unstructured":"Wiles DH, Kolakowska T, McNeilly AS, Mandelbrote BM, Gelder MG (1976) Clinical significance of plasma chlorpromazine levels 1. Plasma levels of the drug, some of its metabolities and prolactin during acute treatment. Psychol Med 6:407?415","journal-title":"Psychol Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1981.tb00761.x","volume":"64","author":"B Wistedt","year":"1981","unstructured":"Wistedt B (1981) A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. Acta Psychiatr Scannd 64:65?84","journal-title":"Acta Psychiatr Scannd"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archpsyc.1982.04290020066012","volume":"39","author":"E Zarifian","year":"1982","unstructured":"Zarifian E, Scatton B, Bianchetti G, Cuche H, Loo H, Morselli PL (1982) High doses of haloperidol in schizophrenia. Arch Gen Psychiatry 39:212?215","journal-title":"Arch Gen Psychiatry"}],"container-title":["European Archives of Psychiatry and Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00380974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00380974\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00380974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:34:48Z","timestamp":1554327288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00380974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,9]]}},"alternative-id":["BF00380974"],"URL":"https:\/\/doi.org\/10.1007\/bf00380974","relation":{},"ISSN":["0175-758X","1433-8491"],"issn-type":[{"value":"0175-758X","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,9]]}}}